Trimethylamine N-oxide explained

Trimethylamine N-oxide (TMAO) is an organic compound with the formula (CH3)3NO. It is in the class of amine oxides. Although the anhydrous compound is known, trimethylamine N-oxide is usually encountered as the dihydrate. Both the anhydrous and hydrated materials are white, water-soluble solids.

TMAO is found in the tissues of marine crustaceans and marine fish, where it prevents water pressure from distorting proteins and thus killing the animal. The concentration of TMAO increases with the depth at which the animal lives; TMAO is found in high concentrations in the deepest-living described fish species, Pseudoliparis swirei, which was found in the Mariana Trench, at a recorded depth of 8076m (26,496feet).[1] [2]

In animals, TMAO is a product of the oxidation of trimethylamine, a common metabolite of trimethyl quaternary ammonium compounds, like choline, trimethylglycine, and L-carnitine.[3] High TMAO concentrations are associated with an increased risk of all-cause mortality and cardiovascular disease.[4] [5] [6]

Marine animals

Trimethylamine N-oxide is an osmolyte found in molluscs, crustaceans, and all marine fishes and bony fishes. It is a protein stabilizer that serves to counteract the protein-destabilizing effects of pressure. In general, the bodies of animals living at great depths are adapted to high pressure environments by having pressure-resistant biomolecules and small organic molecules present in their cells, known as piezolytes, of which TMAO is the most abundant. These piezolytes give the proteins the flexibility they need to function properly under great pressure.[1] [2] [7] [8] [9]

TMAO decomposes to trimethylamine (TMA), which is the main odorant that is characteristic of degrading seafood.

TMAO in diet

TMAO levels increase with consumption of animal protein such as eggs, red meat, shellfish and total fish consumption.[10] [11] Plant-based diets such as vegan, vegetarian and the Mediterranean diet lower TMAO levels.[11] [12]

Chemistry

TMAO can be synthesized from TMA by treatment with hydrogen peroxide:[13]

H2O2 + (CH3)3N → H2O + (CH3)3NO

The dihydrate is dehydrated by azeotropic distillation from dimethylformamide.[14]

Laboratory applications

Trimethylamine oxide is used in protein folding experiments to counteract the unfolding effects of urea.[15]

In the organometallic chemistry reaction of nucleophilic abstraction, Me3NO is employed as a decarbonylation agent according to the following stoichiometry:

M(CO)n + Me3NO + L → M(CO)n−1L + Me3N + CO2

This reaction is used to decomplex organic ligands from metals, e.g. from (diene)Fe(CO)3.[13]

It is used in certain oxidation reactions, e.g. the conversion of alkyl iodides to the corresponding aldehyde.

Effects on protein stability

The effects of TMAO on the backbone and charged residues of peptides are found to stabilize compact conformations,[16] whereas effects of TMAO on nonpolar residues lead to peptide swelling. This suggests competing mechanisms of TMAO on proteins, which accounts for hydrophobic swelling, backbone collapse, and stabilization of charge-charge interactions. These mechanisms are observed in Trp cage.[17]

Disorders

Trimethylaminuria

See main article: Trimethylaminuria. Trimethylaminuria is a rare defect in the production of the enzyme flavin-containing monooxygenase 3 (FMO3).[18] [19] Those suffering from trimethylaminuria are unable to convert choline-derived trimethylamine into trimethylamine oxide. Trimethylamine then accumulates and is released in the person's sweat, urine, and breath, giving off a strong fishy odor.

Health effects

Mortality

High circulating TMAO concentrations are associated with an increased risk of all-cause mortality.[20]

Cardiovascular disease

High circulating TMAO concentrations are associated with an increased risk of cardiovascular events and strokes in particular.[21]

Hypertension

High circulating TMAO concentrations are associated with an increased risk of hypertension.[22] [23]

Potential toxicity

Exposure limit guidelines with a detailed description of toxicity are available such as "Recommendation from the Scientific Committee on Occupational Exposure Limits" by the European Union Commission.[24]

See also

Notes and References

  1. Linley, T.D.. M.E. Gerringer. P.H. Yancey. J.C. Drazen. C.L. Weinstock. A.J. Jamieson. 2016. Fishes of the hadal zone including new species, in situ observations and depth records of Liparidae. Deep Sea Research Part I: Oceanographic Research Papers. 114. 99–110. 10.1016/j.dsr.2016.05.003. 2016DSRI..114...99L. free.
  2. Gerringer, M.E.. T.D. Linley. P.H. Yancey. A.J. Jamieson. E. Goetze. J.C. Drazen. 2016. Pseudoliparis swirei sp. nov.: A newly-discovered hadal snailfish (Scorpaeniformes: Liparidae) from the Mariana Trench. Zootaxa. 4358. 1. 161–177. 10.11646/zootaxa.4358.1.7. 29245485. free.
  3. Baker, J.R. . Chaykin, S. . The biosynthesis of trimethylamine-N-oxide . . 1 April 1962 . 237 . 1309–13 . 13864146 . 4. 10.1016/S0021-9258(18)60325-4 . free .
  4. 2017. Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, Trimarco B, Esposito G, Perrino C.. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. European Heart Journal. 38. 39. 2948–2956. 10.1093/eurheartj/ehx342. 29020409. free.
  5. Li D, Lu Y, Yuan S, Cai X, He Y, Chen J, Wu Q, He D, Fang A, Bo Y, Song P, Bogaert D, Tsilidis K, Larsson SC, Yu H, Zhu H, Theodoratou E, Zhu Y, Li X. . 2022. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis. Am J Clin Nutr. 116. 1. 230–243. 10.1093/ajcn/nqac074. 35348578. 9257469 .
  6. Dean YE, Rouzan SS, Loayza Pintado JJ, Talat NE, Mohamed ARH, Verma S, Anwar Kamdi Z, Gir D, Helmy A, Helmy Z, Afzal A, Mady T, Hazimeh Y, Aiash H.. 2023. Serum trimethylamine N-oxide levels among coronary artery disease and acute coronary syndrome patients: a systematic review and meta-analysis. Annals of Medicine and Surgery. 85. 12. 6123–6133. 10.1097/MS9.0000000000001426. 38098555. 10718322.
  7. Yancey, P. . Organic osmolytes as compatible, metabolic, and counteracting cytoprotectants in high osmolarity and other stresses . . 2005 . 208 . 2819–2830 . 10.1242/jeb.01730 . 16043587 . 15. free .
  8. M.T.. Velasquez. A.. Ramezani. A.. Manal. D.S.. Raj. Trimethylamine N-Oxide: The good, the bad and the unknown. 8 November 2016. Toxins. 8. 11. 326. 10.3390/toxins8110326. 27834801. 5127123. free.
  9. Web site: What does it take to live at the bottom of the ocean? . 2016 . BBC Earth . 19 May 2016 . 13 May 2016 . https://web.archive.org/web/20160513205236/http://www.bbc.co.uk/earth/story/20150129-life-at-the-bottom-of-the-ocean . live.
  10. Yang JJ, Shu XO, Herrington DM, Moore SC, Meyer KA, Ose J, Menni C, Palmer ND, Eliassen H, Harada S, Tzoulaki I, Zhu H, Albanes D, Wang TJ, Zheng W, Cai H, Ulrich CM, Guasch-Ferré M, Karaman I, Fornage M, Cai Q, Matthews CE, Wagenknecht LE, Elliott P, Gerszten RE, Yu D.. 2021. Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis. The American Journal of Clinical Nutrition. 113. 5. 1145–1156. 10.1093/ajcn/nqaa430. 33826706. 8106754 . 10044/1/86226. free.
  11. Lombardo M, Aulisa G, Marcon D, Rizzo G.. 2022. The Influence of Animal- or Plant-Based Diets on Blood and Urine Trimethylamine-N-Oxide (TMAO) Levels in Humans. Curr Nutr Rep. 11. 1. 56–68. 10.1007/s13668-021-00387-9. 34990005.
  12. Evans M, Dai L, Avesani CM, Kublickiene K, Stenvinkel P.. 2023. The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison. Clin Kidney J. 16. 11. 1804–1812. 10.1093/ckj/sfad095. 37915930. 10616480.
  13. A. J. Pearson "Trimethylamine N-Oxide" in Encyclopedia of Reagents for Organic Synthesis, John Wiley & Sons, 2001: New York.
  14. Soderquist, J. A. . Anderson, C. L. . Crystalline anhydrous trimethylamine N-oxide. Tetrahedron Lett.. 1986. 27. 34. 3961–3962. 10.1016/S0040-4039(00)84884-4.
  15. Zou, Q. . The Molecular Mechanism of Stabilization of Proteins by TMAO and Its Ability to Counteract the Effects of Urea . . 2002 . 124 . 7 . 1192–1202 . 10.1021/ja004206b . 11841287 . Bennion . Brian J. . Daggett . Valerie . Murphy . Kenneth P..
  16. 2015-03-03. Regulation and aggregation of intrinsically disordered peptides. Proceedings of the National Academy of Sciences of the United States of America. 112. 9. 2758–2763. 10.1073/pnas.1418155112. 25691742. 4352815. Shea. Joan-Emma. Feinstein. Stuart C.. Lapointe. Nichole E.. Larini. Luca. Levine. Zachary A.. 2015PNAS..112.2758L. free.
  17. Effects of Trimethylamine-N-oxide on the Conformation of Peptides and its Implications for Proteins. Physical Review Letters. 119. 10. 108102. 10.1103/physrevlett.119.108102. 28949191. 2017. Su. Zhaoqian. Mahmoudinobar. Farbod. Dias. Cristiano L.. 2017PhRvL.119j8102S.
  18. Treacy, E.P. . Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication . Human Molecular Genetics . 1998 . 839–45 . 7 . 5 . 10.1093/hmg/7.5.839 . 9536088 . Akerman . BR . Chow . LM . Youil . R . Bibeau . C . Lin . J . Bruce . AG . Knight . M . Danks . DM. free .
  19. Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E . Mild trimethylaminuria caused by common variants in FMO3 gene . Lancet . 1999 . 834–5 . 354 . 9181 . 10485731 . 10.1016/S0140-6736(99)80019-1. 9555588 .
  20. Guasti L, Galliazzo S, Molaro M, Visconti E, Pennella B, Gaudio GV, Lupi A, Grandi AM, Squizzato A. . 2021 . TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis . Intern Emerg Med . 16 . 1 . 201–207 . 10.1007/s11739-020-02470-5 . 32779113 . 221099557.
  21. Zhang H, Yao G. . 2023 . Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies . European Journal of Clinical Nutrition . 77 . 7 . 731–740 . 10.1038/s41430-022-01104-7 . 35468932 . 248368447.
  22. 2020. Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G, Xi X, Zhou X, Fan H.. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis. Adv Nutr. 11. 1. 66–76. 10.1093/advances/nmz064. 31269204. 7442397.
  23. 2024. Han JM, Guo L, Chen XH, Xie Q, Song XY, Ma YL.. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis. Medicine (Baltimore). 103. 1. e36784. 10.1097/MD.0000000000036784. 38181288. 10766215.
  24. Book: Directorate-General for Employment . Social Affairs and Inclusion (European Commission) . Scientific Committee on Occupational Exposure Limits . Nielsen . G. D. . Pospischil . E. . Johanson . G. . Klein . C. L. . Papameletiou . D. . 2017 . SCOEL/REC/179 trimethylamine: recommendation from the Scientific Committee on Occupational Exposure Limits . 2023-12-17 . Publications Office of the European Union. 10.2767/440659 . 978-92-79-66627-8 .